1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,319 | 0,327 | 23.12. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.10. | Theraclion Announces Major Advances and Reports First-Half Financial Results | 333 | Business Wire | On the strength of its progress on its 2023 and 2024 priorities (access to the US market, R&D and China), Theraclion is planning its commercial ramp-up for 2025 and 2026. Pivotal study for... ► Artikel lesen | |
| 06.09. | Theraclion Confirms Strong Mid-Year Achievements | 354 | Business Wire | Main focus: Access to the U.S. market, R&D and China. Key achievements in H1 2024: FDA pivotal study: treatments completed in June on schedule
Promising R&D progress in product features... ► Artikel lesen | |
| 24.06. | SONOVEIN FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule | 546 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE) innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy... ► Artikel lesen | |
| THERACLION Aktie jetzt für 0€ handeln | |||||
| 06.06. | Theraclion: SONOVEIN Highlighted in Top Medical Conferences and Scientific Journal | 512 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces... ► Artikel lesen | |
| 27.03. | Theraclion Announces 2023 Financial Results and Continues Its Roadmap | 343 | Business Wire | Continuation of the strategy focused on access to the US and Chinese markets for SONOVEIN®, and its improvement through R&D;
Rapid start-up of the pivotal study in the United States: two-thirds... ► Artikel lesen | |
| 29.01. | Theraclion Pursues Its Strategy and Announces Its 2023 Revenue | 586 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE), an innovative company developing a scalable robotic platform for non-invasive focused ultrasound therapy (HIFU),... ► Artikel lesen |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GERRESHEIMER | 70,00 | +3,47 % | Gubra, Zealand Pharma, Gerresheimer und Co im Sog von Novo Nordisk - jetzt abstauben? | Kursbeben bei Novo Nordisk. Der dänische Biopharma-Riese konnte die hohen Markterwartungen an CagriSema (Kombination aus einem GLP-1 und Amylin-Analogon) nicht erfüllen. Die Aktie crasht daraufhin um... ► Artikel lesen | |
| INMODE | 16,420 | +0,74 % | InMode Ltd.: InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the ... | YOKNEAM, Israel, Oct. 30, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| MCKESSON | 554,20 | -0,04 % | Jim Cramer Says He 'Would Not Buy' McKesson Corporation (MCK) | ||
| HCA HEALTHCARE | 289,30 | -0,82 % | HCA Healthcare Stock Trades at Premium: Time to Buy or Hold? | ||
| LIMES SCHLOSSKLINIKEN | 326,00 | +0,62 % | EQS-Adhoc: Limes Schlosskliniken AG: Positiver Geschäftsverlauf I. Halbjahr 2024 | EQS-Ad-hoc: Limes Schlosskliniken AG / Schlagwort(e): Halbjahresbericht/Vorläufiges Ergebnis
Limes Schlosskliniken AG: Positiver Geschäftsverlauf I. Halbjahr 2024
18.07.2024 / 10:17 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| BEYOND AIR | 0,390 | -7,14 % | Beyond Air, Inc. - 8-K, Current Report | ||
| CLEARDAY | - | - | Clearday, Inc.: Tech Centric Healthcare Services Company Continues To Move Forward With Its Business Combination and Exchange Listing | San Antonio, Texas, July 22, 2024 (GLOBE NEWSWIRE) -- Clearday (CLRD:OTC EXMKT) ("Clearday" or the "Company") is pleased to inform market participants, partners and stakeholders of the Company's efforts... ► Artikel lesen | |
| HEALTHCARE SERVICES GROUP | 10,700 | -0,93 % | HCSG Reports Q3 2024 Results | BENSALEM, Pa.--(BUSINESS WIRE)--Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended September 30, 2024.
Ted Wahl, Chief Executive Officer, stated, "We're... ► Artikel lesen | |
| INTERPACE BIOSCIENCES | 2,400 | 0,00 % | Interpace Biosciences, Inc.: Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results | Q3 Revenue of $12.3 million; a $3.2M and 35% increase year-over-year Q3 Test volume up 26% year over year to record levels Q3 Cash collections of $11.3M; a $1.4M and 15% increase year-over-year Q3... ► Artikel lesen | |
| SIENNA SENIOR LIVING | 10,500 | +0,96 % | Dividendenbekanntmachungen (29.11.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3I GROUP PLC ADR US88579N1054 0,1933 USD 0,1831 EUR AAON INC US0003602069 0,08 USD 0,0757 EUR ACADEMEDIA AB SE0007897079 1,75... ► Artikel lesen | |
| ADDUS HOMECARE | 125,00 | 0,00 % | Addus HomeCare Completes Acquisition of Personal Care Operations of Gentiva | FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced it has completed the acquisition of the personal care operations of... ► Artikel lesen | |
| IVF HARTMANN | 160,51 | -0,96 % | IVF Hartmann im ersten Halbjahr mit mehr Gewinn | Neuhausen - Der Medizinalbedarfhersteller IVF Hartmann hat im ersten Halbjahr 2024 mehr Umsatz erzielt und deutlich mehr verdient. Im Gesamtjahr will der Konzern weiter zulegen. Der Umsatz stieg im... ► Artikel lesen | |
| ICU MEDICAL | 150,00 | +0,67 % | Smiths Group Sells 1.2 Mln Shares In ICU Medical | LONDON (dpa-AFX) - Smiths Group Plc (SMIN.L), an engineering firm, confirmed on Wednesday that it has sold 1.2 million shares in ICU Medical Inc. or around 4.9 percent of ICU's share capital.... ► Artikel lesen | |
| MODERN DENTAL | 0,498 | -3,30 % | MODERN DENTAL (03600): NEXT DAY DISCLOSURE RETURN |
Das Unternehmen THERACLION kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,316 Euro und damit +4,29 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu THERACLION finden Sie auf Wallstreet Online.
